Glucagon modulates proliferation and differentiation of human adipose precursors

被引:12
作者
Cantini, Giulia [1 ]
Trabucco, Martina [1 ]
Di Franco, Alessandra [1 ]
Mannucci, Edoardo [1 ,2 ]
Luconi, Michaels [1 ,2 ]
机构
[1] Univ Florence, Dept Expt & Clin Biomed Sci, Endocrinol Unit, Florence, Italy
[2] Careggi Hosp, AOUC, Florence, Italy
关键词
glucagon; adipose tissue; glucagon receptor; GLP-1 receptor agonists; GLP-1; RECEPTOR; PEPTIDE-1; OXYNTOMODULIN; LIRAGLUTIDE; ANTAGONIST; MECHANISM; EVOLUTION; INFUSION; BIOLOGY; AGONIST;
D O I
10.1530/JME-19-0095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucagon-like peptide 1 receptor agonists (GLP-1RAs), which are currently used for the treatment of type 2 diabetes, have recently been proposed as anti-obesity drugs, due to their relevant effects on weight loss. Furthermore, dual agonists for both GLP-1R and glucagon receptor (GCGR) are under investigation for their promising action on adiposity, although underlying mechanisms still need to be clarified. We have recently demonstrated that GLP-1 and liraglutide interfere with the proliferation and differentiation of human adipose precursors, supporting the hypothesis of a peripheral action of GLP-1RA on weight. Here, we investigated glucagon activity in an in vitro model of primary human adipose-derived stem cells (ASCs). Glucagon significantly inhibited ASC proliferation in a dose- and time-dependent manner, as evaluated by cell count and thymidine incorporation. When added during in vitro-induced adipogenesis, glucagon significantly reduced adipocyte differentiation, as demonstrated by the evaluation of intracellular fat content and quantitative expression of early and mature adipocyte markers (PPAR gamma and FABP4, HSL). Notably, the inhibitory effect of glucagon on cell proliferation and adipogenesis was reversed by specific GLP-1R (exendin-9) and GCGR (des-His(1)-Glu(9)-glucagon(1-29)) antagonists. The presence of both receptors was demonstrated by Western blot, immunofluorescence and cytofluorimetric analysis of ASCs. In conclusion, we demonstrated a direct inhibitory action of glucagon on the proliferation and differentiation of human adipose precursors, which seems to involve both GLP-1R and GCGR. These findings suggest that the adipose stem compartment is a novel target of glucagon, possibly contributing to the weight loss obtained in vivo with dual GLP-1R/glucagon agonists.
引用
收藏
页码:249 / 260
页数:12
相关论文
共 36 条
[1]   Glucagon - Early breakthroughs and recent discoveries [J].
Ahren, Bo .
PEPTIDES, 2015, 67 :74-81
[2]   The biology of glucagon and the consequences of hyperglucagonemia [J].
Albrechtsen, Nicolai J. Wewer ;
Kuhre, Rune E. ;
Pedersen, Jens ;
Knop, Filip K. ;
Holst, Jens J. .
BIOMARKERS IN MEDICINE, 2016, 10 (11) :1141-1151
[3]   Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? [J].
Arafat, A. M. ;
Kaczmarek, P. ;
Skrzypski, M. ;
Pruszynska-Oszmalek, E. ;
Kolodziejski, P. ;
Szczepankiewicz, D. ;
Sassek, M. ;
Wojciechowicz, T. ;
Wiedenmann, B. ;
Pfeiffer, A. F. H. ;
Nowak, K. W. ;
Strowski, M. Z. .
DIABETOLOGIA, 2013, 56 (03) :588-597
[4]  
Astrup A, 2000, Obes Rev, V1, P57, DOI 10.1046/j.1467-789x.2000.00013.x
[5]   Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure [J].
Bagger, Jonatan Ising ;
Holst, Jens Juul ;
Hartmann, Bolette ;
Andersen, Birgitte ;
Knop, Filip Krag ;
Vilsboll, Tina .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (12) :4541-4552
[6]   Functional Differences in Visceral and Subcutaneous Fat Pads Originate from Differences in the Adipose Stem Cell [J].
Baglioni, Silvana ;
Cantini, Giulia ;
Poli, Giada ;
Francalanci, Michela ;
Squecco, Roberta ;
Di Franco, Alessandra ;
Borgogni, Elisa ;
Frontera, Salvatore ;
Nesi, Gabriella ;
Liotta, Francesco ;
Lucchese, Marcello ;
Perigli, Giuliano ;
Francini, Fabio ;
Forti, Gianni ;
Serio, Mario ;
Luconi, Michaela .
PLOS ONE, 2012, 7 (05)
[7]   Characterization of human adult stem-cell populations isolated from visceral and subcutaneous adipose tissue [J].
Baglioni, Silvana ;
Francalanci, Michela ;
Squecco, Roberta ;
Lombardi, Adriana ;
Cantini, Giulia ;
Angeli, Roberta ;
Gelmini, Stefania ;
Guasti, Daniele ;
Benvenuti, Susanna ;
Annunziato, Francesco ;
Bani, Daniele ;
Liotta, Francesco ;
Francini, Fabio ;
Perigli, Giuliano ;
Serio, Mario ;
Luconi, Michaela .
FASEB JOURNAL, 2009, 23 (10) :3494-3505
[8]   Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo [J].
Bertin, E ;
Arner, P ;
Bolinder, J ;
Hagström-Toft, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) :1229-1234
[9]   Is cleaved glucagon-like peptide 1 really inactive? Effects of GLP-1(9-36) on human adipose stem cells [J].
Cantini, Giulia ;
Di Franco, Alessandra ;
Mannucci, Edoardo ;
Luconi, Michaela .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 439 (0C) :10-15
[10]   Perspectives in GLP-1 Research: New Targets, New Receptors [J].
Cantini, Giulia ;
Mannucci, Edoardo ;
Luconi, Michaela .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2016, 27 (06) :427-438